1) Lupin launches osteoarthritis drug -
• Pharmaceutical Sector
• Featured
• TNM
• Product Launch
• Lupin
• India
Indian pharmaceutical company Lupin on Thursday launched its new medicine for degenerative joint disease osteoarthritis, Hyalgan. It's an injectable liquid drug to relieve a patient from pain caused from osteoarthritis, a company statement said. The drug is injected directly into the knees.
Nearly 12 per cent of the population in India is affected by osteoarthritis, which is a major health problem in the country today among the 25-30 age group. As revealed by a survey at present the market for such medicines worth nearly Rs. 150 crore, Lupin said in its statement.
By-ASHISH KUMAR SINGH
PGDM 2ND SEM
• Pharmaceutical Sector
• Featured
• TNM
• Product Launch
• Lupin
• India
Indian pharmaceutical company Lupin on Thursday launched its new medicine for degenerative joint disease osteoarthritis, Hyalgan. It's an injectable liquid drug to relieve a patient from pain caused from osteoarthritis, a company statement said. The drug is injected directly into the knees.
Nearly 12 per cent of the population in India is affected by osteoarthritis, which is a major health problem in the country today among the 25-30 age group. As revealed by a survey at present the market for such medicines worth nearly Rs. 150 crore, Lupin said in its statement.
By-ASHISH KUMAR SINGH
PGDM 2ND SEM
No comments:
Post a Comment